34, 509-518. TNF administration mimics ischemic preconditioning and neutralizing antibodies to TNF and IL-1 abolish exercise-induced preconditioning. However, the pharmacology of TNF 's cardioprotective effects and associated downstream signaling events has not been delineated. We evaluated the temporal and dose specific requirements of TNF to function as a preconditioning mimetic. Furthermore we postulated that the preconditioning effect of TNF might be orchestrated via sphingolipid signaling. The cardioprotective effect of TNF and the role of sphingolipid signaling were assessed using a classical preconditioning protocol in the isolated perfused rat heart with the measurement of infarct size and contractile function modulation in response to index ischemia and reperfusion. Recombinant TNF at an optimal dose of 0.5 ng/ml mimicked ischemic preconditioning by reducing infarct size by 60% v non-preconditioned ischemia-reperfusion controls (P<0.01). The infarct sparing effect of TNF required a wash-out period prior to the index ischemic-reperfusion. Moreover, the classic ischemic preconditioning antagonist such as 5-hydroxydecanoate abolished TNF preconditioning. An inhibitor of the sphingolipid signaling pathway, N-oleoylethanolamine (NOE, 1 ) attenuated ischemic and TNF preconditioning. Likewise, cell-permeable C 2 -ceramide and sphingosine 1-phosphate (sphingolipid signaling intermediates) both reproduced the preconditioning cardioprotective phenotype. Finally, TNF and ceramide conferred preconditioning-like cardioprotection against post-ischemic contractile dysfunction and this cardioprotective effect was attenuated by NOE. In contrast, NOE did not reverse ischemic preconditioning enhanced post-ischemic contractile function. In conclusion, TNF activates preconditioning-like tolerance against infarction and contractile dysfunction. This cardioprotection is mediated, in part, via activation of novel sphingolipid signaling intermediates.
Introduction
to evoke preconditioning in rats and rabbits. [4] [5] [6] [7] Moreover, we have demonstrated that TNF is Preconditioning with short episodes of non-lethal ischemia augments innate cardiac resistance tonecessary for ischemic preconditioning in the isolated perfused mouse heart and that this cytokine wards subsequent ischemic injury. 
Materials and Methods
phenotype in the intact mouse heart. 8 The pharmacology and the signaling events initiated by All experiments were conducted on adult male Long-Evans rats weighing 250-300 g in ac-TNF binding to its cognate type II cell membrane receptors have not been extensively explored with cordance with the Guide for the Care and Use of Laboratory Animals (National Academic Press, respect to preconditioning activated cell survival signaling. In this regard, the TNF interaction with Washington DC, 1996) . The University of Cape Town Medical School Research Ethics Committee its cell surface receptors is known to interact with the sphingolipid pathway by activating the neutral approved all experiments. Of note, rats used in experiments described in Figures 2 to 4 were obsphingomyelinase, an enzyme that hydrolyses sphingomyelin to generate the intracellular second tained from Elevage Depre, France while all the other rats were obtained from the animal facility messenger ceramide. 9 Ceramide, in the presence of ceramidase and sphingosine kinase, will then form at the University of Cape Town, South Africa. sphingosine and sphingosine 1-phosphate. This sphingolipid signaling pathway leads to multiple biological actions including regulatory roles in Isolated rat heart model apoptosis, growth, cell survival and inflammation. [10] [11] [12] Rats were anesthetized with 60 mg/kg intraperitoneal sodium pentobarbitone and given an TNF has been shown to promote divergent cellular effects spanning from cell survival to cell death intravenous injection of 200 IU heparin. Hearts were excised rapidly and placed in ice-cold Krebsin the heart (reviewed Ref. 13). These conflicting biologic effects may be mediated, in part, via acHenseleit perfusion buffer before being mounted on a Langendorff apparatus for perfusion at 37°C with tivation of the sphingolipid signaling intermediates.
9,14 Hence, we hypothesized that TNF Krebs-Henseleit buffer at constant pressure (100 cm H 2 O). The buffer was equilibrated with may direct its preconditioning-like effects via sphingolipid signaling. In this study, we have focussed 95% CO 2 /5% O 2 and had the following composition (m): NaCl 118.0, KCl 4.7, CaCl 2 1.2, KH 2 PO 4 1.2, on characterizing the dose and temporal requirements of TNF in the preconditioning proMgSO 4 1.2, NaHCO 3 25.2 and glucose 11.0. For hearts subjected to a regional ischemia experiments, gram. Furthermore we evaluated the role of the sphingolipid signaling intermediate-ceramide-in a 6/0 silk suture was placed around the left coronary artery to form a snare. A balloon was inserted preconditioning and finally we characterized the interplay between TNF signaling and classical through the left atrium into the left ventricle and the left-ventricular end diastolic pressure (LVEDP) ischemic preconditioning activated cell signaling.
Of note, studies by numerous investigators have was adjusted between 4 and 8 mmHg. Cardiac parameters were monitored continuously and indemonstrated that the sham-procedure to open the chest and a cardiac ischemia-reperfusion in vivo cluded heart rate (HR), left ventricular developed pressure (LVDP: difference between left ventricular result in the acute and sustained activation of numerous cytokines, including TNF , IL-1 and ILend systolic pressure and end diastolic pressure), the rate-pressure product [left ventricular developed 6. [15] [16] [17] Hence, in order to dissect out the relative contribution of TNF we have used a reductionist pressure multiplied by the heart rate (RPP)] and the coronary flow (CF). approach, i.e. the isolated perfused rat heart, to study TNF and sphingolipid intermediate signaling in classical preconditioning. In this study we found that TNF mimics ischemic preconditioning in a Experimental protocols dose and temporal dependent manner. Moreover, we demonstrate that TNF protects against post-
The perfusion protocol is shown in Figure 1 . All hearts were allowed to equilibrate for at least 15 min ischemic infarction and contractile dysfunction. We also demonstrate that considerable overlap exists and were consequently subjected to a standard 30 min of regional [ Fig. 1(A) ] or global ischemia between classical ischemia and TNF activated preconditioning with regard to intracellular signaling [ Fig. 1(B) ] followed by 120 and 30 min of reperfusion respectively. IPC was elicited by two cycles events. Finally, we identify a novel sphingolipid signaling cascade that seems to participate both of 5 min of global ischemia interspersed with 5 min reperfusion prior to the standard ischemia. in ischemic preconditioning and TNF mediated cardioprotection against infarction in the isolated TNF (from 0.05 to 5 ng/ml), the cell permeable c2-ceramide (1 ) or sphingosine 1-phosphate perfused rat heart.
Figure 1
Experimental protocol conducted on an isolated rat heart model. All hearts underwent at least 15 min of a stabilization period. In part (A), hearts were subjected to 30 min of regional ischemia followed by 2 h reperfusion. In part (B), hearts were subjected to 30 min of global ischemia followed by 30 min of reperfusion. Hearts were preconditioned with two short episodes of global ischemia or pretreated with either TNF (0.05 to 5 ng/ml) or ceramide (1 ) in the presence or absence of 5-HD (100 ), chelerythrine (10 ) or NOE (1 or 5 ).
(10 n) were given for 7 min followed by 10 min of period and a solution of 2.5% Evans blue was perfused to delineate the area of risk. Hearts were reperfusion before the standard ischemia. Additional groups were perfused with 5-hydroxydecanoic acid then frozen and cut into slices, incubated in sodium phosphate buffer containing 1% w/v trisodium (5-HD; 100 ), a blocker of the mitochondrial K ATP channel 18 or N-oleoylethanolamine phenyltetrazolium chloride (TTC) for 15 min to visualize the unstained infarcted region. Infarct (NOE; 1 or 5 ), a relatively specific inhibitor of the ceramidase 19 for 15 min followed by 5 min washout and risk zone areas were determined with planimetry and infarct was expressed as a percentage prior to the I/R insult. All drugs were infused directly above the heart alone or in the presence of TNF of the risk zone. (0.5 ng/ml), ceramide (1 ) or an ischemic preconditioning stimulus. An additional group of hearts were pretreated with TNF (0.5 ng/ml) for 7 min and Pharmacologic agents subjected directly to a standard ischemia-reperfusion period without any washout.
Recombinant rat tumour necrosis factor alpha was obtained from Pepro Tech EC Ltd (London, UK), 5-hydroxydecanoic acid was purchased from Research Biochemicals International (Natick, USA) Measurement of the area of risk and all other drugs were obtained from Sigma Chemical Company (St Louis, MO, USA). In the regional ischemic model, the coronary artery was reoccluded at the end of the reperfusion cending artery and 2 h of reperfusion. Infarct size was Infarct size was expressed as a percentage of the risk expressed as a percentage of the risk zone. Hearts were zone. Hearts were perfused with TNF 0.05, 0.5, 1 or preconditioned (IPC) with two short episodes of global 5 ng/ml prior to ischemia. * P<0.01 v control group. n= ischemia or were perfused with TNF 0.5 ng/ml with or 6 in each group.
without a washout of 10 min prior to the ischemia. * P<0.01 v control group. n=6 in each group.
Statistical analysis
All results are expressed as mean±standard error of the mean (n=6 to 12 animals per group). For multiple comparisons, ANOVA followed by the Tukey's post hoc procedure was applied to isolate significant differences. A P value <0.05 was considered significant. 2). The optimal TNF dose of 0.5 ng/ml administered as a preconditioning-mimetic resulted in a significant reduction in infarct size compared activation by co-administration of the mitowith the control group (12.0±2.5 v 34.9±4.9, chondrial K ATP channel antagonist 5-hydroxy-P<0.01). The protective effect afforded by TNF decanoate. Here, 5-HD completely blocked the was similar to the protective effect induced by cardioprotective effect of the preconditioning-miischemic preconditioning (12.0±2.5 v 13.2±2.7) metic effect of TNF (infarct size (Fig. 3) . When 0.5 ng/ml of recombinant TNF was TNF −12.0±2.5% v TNF +5-HD−28.5±3.9%, infused up to the moment of the index ischemic Fig. 4) . insult, i.e. no washout period, the infarct sparing effect was abolished, resulting in a similar size infarct to the ischemic controls (33.0±7.7 v Sphingolipid signaling in TNF activated preconditioning 34.9±4.9, P=.., Fig. 3) .
Results

Recombinant TNF administration mimics ischemic preconditioning
Ischemic preconditioning is known to be abAs a putative cytoprotective pathway downstream of TNF induces sphingolipid second messenger olished by inhibition of mitochondrial K ATP channel mediated signaling 14 we began to interrogate this infarct size in a similar extent to ceramide (P<0.001) (Fig. 6 ). signaling pathway in our study. Interestingly, the ceramidase inhibitor, NOE (1 ) abolished the infarct sparring effects of both ischemic preconditioning and of TNF (Fig. 5 ). In addition, 1  of cell-permeable C 2 -ceramide, a sphingolipid TNF activated preconditioning enhances post-ischemic ventricular functional recovery signaling intermediate significantly reduced the infarct size compared to non-preconditioned controls As protection against stunning is an additional (19.1±4.1% v 55.0±5.3, P<0.001, Fig. 6 ). This preconditioning-like effect of C 2 -ceramide could be relevant end-point of preconditioning 23 we evaluated the role of the optimal dose of TNF (0.5 ng/ml) abolished by the ceramidase inhibitor, NOE. However, here a higher dose of NOE was required (5 ), on contractile recovery following global ischemia in the isolated perfused rat heart. The ischemic control as compared to the dose required to inhibit the TNF and ischemic preconditioning cardiogroup resulted in a marked decrease in the LVDP, RPP and the coronary flow compared to the preprotective effects (1 ) (Fig. 6 ). This discrepancy may be due of different pharmacokinetics between ischemic values (hemodynamic data shown in Table  1 ). The IP "trigger" resulted in augmented LVDP endogenous ceramide produced by TNF and the exogenous C 2 -ceramide. Of note, both doses of NOE (P<0.001), in an improved RPP (Fig. 7) (P<0.001) and an increase in coronary flow (P<0.001) after have been used as ceramidase inhibitor in cardiovascular system. [19] [20] [21] As with the other pre-30 min of reperfusion compared to controls. Addition of recombinant TNF , 0.5 ng/ml did conditioning-like triggers, the proposed mitochondrial K ATP channel antagonist, 5-hydroxynot modify the hemodynamic parameters before ischemia but resulted in a greater LVDP (P<0.001) decanoate also abolished the preconditioning-like effect of ceramide (Fig. 6) . Perfusion of sphingosine and functional recovery (Fig. 7) (57.6±3.2% v 20.0±3.4% for controls, P<0.001) after the index 1-phosphate (10 n) 22 prior to the ischemia/reperfusion insult conferred cardioprotection against I/R compared to the ischemic controls. Perfusion of 5-HD (100 ) alone had no sigischemic control hearts (P<0.001). Co-perfusion of NOE (5 ) with C 2 -ceramide abolished the pronificant effect of hemodynamic functions in hearts subjected to an I/R insult. However, co-adtective effect of C 2 -ceramide (Table 1) . ministration of 5-HD (100 ) in the TNF preconditioned hearts abolished the protective effects measured following the index I/R insult. The LVDP Discussion decreased from 62.9±3.5 mmHg to 22.3±2.7 mmHg (P<0.001) and the functional
In this study we demonstrate that TNF mimics classical ischemic preconditioning and has both recovery decreased from 57.6±3.2% to 13.2±1.9% (P<0.001). We have previously deman infarct sparing effect and contributes towards improved post-ischemic functional recovery in the onstrated the ability of 5-HD administration to abolish the protection conferred by ischemic preisolated perfused rat heart. Moreover, pharmacologic antagonist studies support a role for conditioning in this model. 24 Addition of the ceramidase inhibitor NOE (1 ) TNF activated preconditioning through the classical preconditioning mediated mitochondrial K ATP 15 min before ischemia did not modify the coronary flow and the LVDP of the heart, during the perfusion channel activation. Concurrently, the role of sphingolipid intermediate signaling is suggested by the or after 30 min of reperfusion. However, co-perfusion of NOE with 0.5 ng/ml TNF significantly abrogation of TNF cardioprotective effects with Noleoylethanolamine and due to the ability of cellabolished the effect of TNF and decreased the LVDP (P<0.01) and functional recovery (Fig. 7) permeable C 2 -ceramide and sphingosine 1-phosphate to parallel TNF effects. Finally, as NOE at-(P<0.001) after 30 min of reperfusion compared to the hearts pretreated with TNF alone.
tenuates ischemic preconditioning-directed infarct sparing effects but not its contractile recovery efPerfusion of C 2 -ceramide (1 ) did not modify the hemodynamics parameters of the heart before fects, putative alternate regulatory pathways may drive these divergent end-points of ischemic preglobal ischemia insult but resulted in a greater LVDP during the reperfusion period compared to the conditioning.
Table 1
Pre-and post-ischemic hemodynamic parameters in the group of hearts exposed to global ischemia and reperfusion [protocol: Fig. 1(B A central role for reactive oxygen species in the (reviewed Refs 13, 34). As TNF signaling can activate PKC and MAPK signaling, 35,36 the finding induction of preconditioning is becoming increasingly apparent. [25] [26] [27] As TNF is known to be that the conventional pharmacologic antagonists of preconditioning such as 5-hydroxydecanoate abupregulated by oxidative stress, 14, 28, 29 it should not be surprising that TNF plays a role in the preolish TNF preconditioning is not unexpected. The fact that TNF pretreatment without being washed conditioning program. Likewise, TNF biosynthesis has been indirectly associated with ischemic preout prior to ischemia/reperfusion did not confer cardioprotection may be explained via a toxic effect conditioning in the intact rabbit. 30 Using recombinant TNF administration we also of TNF during the ischemic period. Concurrently sphingolipid intermediates have been identified as demonstrate that this cytokine mimics preconditioning in that a washout period is required TNF activated signaling molecules that have recently emerged as putative modulators of cell surprior to the index ischemia to activate the cardioprotective preconditioning phenotype. Hence, in vival programs. 14, 37 Here, TNF is a known agonist of sphingomyelinase, a family of enzymes that hyparallel with the other adaptive effects of TNF in response to biomechanical stresses in the heart, [31] [32] [33] drolyse sphingomyelin to generate the lipid second messenger ceramide. Ceramide, in turn, in parallel TNF signaling may be a representative of the innate-immune response to oxidative stress proto TNF has strikingly different biologic effects that span from the promotion of cell survival to the duced by ischemia preconditioning.
The pleiotropic effects of TNF signaling result promotion of apoptosis. 12, 14, 38 In this study we demonstrate that both C 2 -ceramide and sphingosine 1-from ligand-induced trimerization of TNF receptors with recruitment of a multitude of adaptor proteins, phosphate mirrored the cardioprotective effects of TNF and that the ceramidase antagonist, NOE preconditioning independent of the known ac- In conclusion, our study demonstrates that TNF , 
